Evidence map›Paper›PMID 22379106›Full record

ArticleMolecular biology of the cell2012

Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals.

Frauke Goeman, Isabella Manni, Simona Artuso, Balaji Ramachandran, Gabriele Toietta, Gianluca Bossi, Gianpaolo Rando, Chiara Cencioni, Sabrina Germoni, Stefania Straino and 6 more

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcoma.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  6. Article
  7. NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. NF-Y Overexpression in Liver Hepatocellular Carcinoma (HCC).International journal of molecular sciences · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Frauke GoemanExperimental Oncology Department, Istituto Regina Elena, 00158 Rome, Italy.
Isabella Manni
Simona Artuso
Balaji Ramachandran
Gabriele Toietta
Gianluca Bossi
Gianpaolo Rando
Chiara Cencioni
Sabrina Germoni
Stefania Straino
Maurizio C Capogrossi
Silvia Bacchetti
Adriana Maggi
Ada Sacchi
Paolo Ciana
Giulia Piaggio
Istituto di Sessuologia Clinica · ITUniversity of Milan · ITIstituto Dermopatico dell'Immacolata · ITCentro Cardiologico Monzino · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo imaging involving the use of genetically engineered animals is an innovative powerful tool for the noninvasive assessment of the molecular and cellular events that are often targets of therapy. On the basis of the knowledge that the activity of the nuclear factor-Y (NF-Y) transcription factor is restricted in vitro to proliferating cells, we have generated a transgenic reporter mouse, called MITO-Luc (for mitosis-luciferase), in which an NF-Y-dependent promoter controls luciferase expression. In these mice, bioluminescence imaging of NF-Y activity visualizes areas of physiological cell proliferation and regeneration during response to injury. Using this tool, we highlight for the first time a role of NF-Y activity on hepatocyte proliferation during liver regeneration. MITO-Luc reporter mice should facilitate investigations into the involvement of genes in cell proliferation and provide a useful model for studying aberrant proliferation in disease pathogenesis. They should be also useful in the development of new anti/proproliferative drugs and assessment of their efficacy and side effects on nontarget tissues.

Indexed as

Cell ProliferationLiver RegenerationMolecular ImagingTranscription, GeneticAnimalsCCAAT-Binding FactorCell CycleCell LineCyclin B2DNA-Binding ProteinsGenes, ReporterLuciferasesMiceMice, TransgenicPromoter Regions, GeneticCCAAT-Binding FactorCcnb2 protein, mouseCyclin B2DNA-Binding ProteinsLuciferases

Identifiers

PMID22379106
PMCPMC3327325
OpenAlexW2171360583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.